These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 30226787)
1. Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor. Pardridge WM; Boado RJ; Patrick DJ; Ka-Wai Hui E; Lu JZ Mol Pharm; 2018 Nov; 15(11):5207-5216. PubMed ID: 30226787 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Pardridge WM Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991 [TBL] [Abstract][Full Text] [Related]
3. Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice. Sun J; Boado RJ; Pardridge WM; Sumbria RK Mol Pharm; 2019 Aug; 16(8):3534-3543. PubMed ID: 31199881 [TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1. Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587 [TBL] [Abstract][Full Text] [Related]
5. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier. Boado RJ; Zhang Y; Zhang Y; Pardridge WM Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408 [TBL] [Abstract][Full Text] [Related]
6. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse. Boado RJ; Zhang Y; Wang Y; Pardridge WM Biotechnol Bioeng; 2009 Mar; 102(4):1251-8. PubMed ID: 18942151 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Yu YJ; Atwal JK; Zhang Y; Tong RK; Wildsmith KR; Tan C; Bien-Ly N; Hersom M; Maloney JA; Meilandt WJ; Bumbaca D; Gadkar K; Hoyte K; Luk W; Lu Y; Ernst JA; Scearce-Levie K; Couch JA; Dennis MS; Watts RJ Sci Transl Med; 2014 Nov; 6(261):261ra154. PubMed ID: 25378646 [TBL] [Abstract][Full Text] [Related]
8. Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey. Boado RJ; Hui EK; Lu JZ; Pardridge WM Mol Pharm; 2016 Sep; 13(9):3241-6. PubMed ID: 27513815 [TBL] [Abstract][Full Text] [Related]
9. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Pardridge WM; Boado RJ Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26. Thom G; Burrell M; Haqqani AS; Yogi A; Lessard E; Brunette E; Delaney C; Baumann E; Callaghan D; Rodrigo N; Webster CI; Stanimirovic DB Mol Pharm; 2018 Apr; 15(4):1420-1431. PubMed ID: 29485883 [TBL] [Abstract][Full Text] [Related]
12. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein. Boado RJ; Pardridge WM Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069 [TBL] [Abstract][Full Text] [Related]
13. Brain iron homeostasis. Moos T Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165 [TBL] [Abstract][Full Text] [Related]
14. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse. Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349 [TBL] [Abstract][Full Text] [Related]
15. Kinetics of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor. Pardridge WM Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056060 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor. Boado RJ; Zhou QH; Lu JZ; Hui EK; Pardridge WM Mol Pharm; 2010 Feb; 7(1):237-44. PubMed ID: 19921848 [TBL] [Abstract][Full Text] [Related]
17. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
18. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pardridge WM; Kang YS; Buciak JL; Yang J Pharm Res; 1995 Jun; 12(6):807-16. PubMed ID: 7667183 [TBL] [Abstract][Full Text] [Related]
19. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts. Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785 [TBL] [Abstract][Full Text] [Related]
20. Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice. Castellanos DM; Sun J; Yang J; Ou W; Zambon AC; Pardridge WM; Sumbria RK Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32911688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]